دورية أكاديمية
Economic Impact of Schizophrenia from a Hospital and Social Security System Perspective in Italy
| العنوان: | Economic Impact of Schizophrenia from a Hospital and Social Security System Perspective in Italy |
|---|---|
| المؤلفون: | Mennini F. S., Marcellusi A., Gazzillo S., Nardone C., Sciattella P., Migliorini R., Trabucco Aurilio M., Amore M., Brugnoli R. |
| المساهمون: | Mennini, F. S., Marcellusi, A., Gazzillo, S., Nardone, C., Sciattella, P., Migliorini, R., Trabucco Aurilio, M., Amore, M., Brugnoli, R. |
| المصدر: | ftunivgenova |
| بيانات النشر: | Adis 5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND |
| سنة النشر: | 2021 |
| مصطلحات موضوعية: | Health Care Cost, Hospitalization, Hospital, Human, International Classification of Disease, Italy, Patient Discharge, Schizophrenia, Social Security, State Medicine, Cost of Illness, demo, eco |
| الوصف: | Background: Schizophrenia is one of the mental disorders with the highest economic and social costs, with an important burden on patients, caregivers, and society. Objective: The objective of this study was to estimate the direct and social security costs of schizophrenia in Italy. As far as direct costs are concerned, those related to hospitalizations and pharmaceutical expenditure have been analyzed, while disability benefits (DBs) and incapacity pensions (IPs) have been considered for the social security costs. Methods: In order to provide annual economic burden of schizophrenia using the real-world data, we analyzed the main regional and national databases related to hospitalizations and pharmaceuticals. Hospitalizations have been analyzed considering the Hospital Information System, which collects all the information regarding hospital discharges from all public and private hospitals (psychiatric wards or residential facilities have not been considered). Hospitalizations with a discharge date between 2009 and 2016, and with a primary or secondary diagnosis of schizophrenia (International Classification of Diseases, Ninth Revision, Clinical Modification [ICD-9-CM] code 295.xx) were selected. Hospital costs have been estimated considering the national tariffs associated with each selected hospitalization. In addition, using the same inclusion criteria, the average DBs (for workers with reduced working capacity) and IPs (for workers without working capacity) provided each year have been analyzed from the social security benefit applications database. The estimate of pharmaceutical expenditure was prepared based on the OsMed 2018 Report (Italian Medicines Agency, latest issue 18 July 2019). A one-way deterministic sensitivity analysis was conducted to examine the robustness of the results. Results: In Italy from 2009 to 2016, schizophrenia had an important economic impact from a social perspective. On average, 13,800 patients were hospitalized, with an average of 2.98 hospitalizations per patient. From a . |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| العلاقة: | http://hdl.handle.net/11567/1069361Test |
| الإتاحة: | http://hdl.handle.net/11567/1069361Test |
| حقوق: | undefined |
| رقم الانضمام: | edsbas.55AB470E |
| قاعدة البيانات: | BASE |
| الوصف غير متاح. |